White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry)

Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

Comparative analysis of recurrent events after presentation with an index myocardial infarction or ischaemic stroke

Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions

Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association

Developing and Testing a Personalized, Evidence-Based, Shared Decision-Making Tool for Stent Selection in Percutaneous Coronary Intervention Using a Pre-Post Study Design